9th Report - The impact of Brexit on the pharmaceutical sector
- HC No.
- HC 382
- Published
- 17 May 2018
- Items
- 0
- Government response
- Government response published 16 July 2018. Read the government's response ↗
Select committee: Business, Innovation, Science and Trade Committee
Brexit and the implications for UK business: Pharmaceuticals inquiry
Closed
Opened 20 Sep 2017
Closed 14 Sep 2017
Business, Innovation, Science and Trade Committee Inquiry on parliament.uk ↗
Inquiry scope (the committee's words)
This is the pharmaceuticals strand of the Committee's Brexit and the implications for UK business inquiry . The Committee aims to establish how the interests of different sectors should best be pursued both in the negotiating process and post-Brexit and attempts to examine a range of issues relating to market access, non-tariff barriers, regulation, skills, R&D, trade opportunities and transitional arrangements. Terms of reference: Brexit and the implications for UK business
Where it stands
The inquiry is closed, opened 20 September 2017.
The committee has published 1 report, most recently 9th Report - The impact of Brexit on the pharmaceutical sector on 17 May 2018.
The government's response
Published 16 July 2018.
Summary written by Accountability Index from the government's response. It is not the government's own words.The government welcomes the report and says many of its recommendations align with its negotiating approach, while stating that it "cannot pre-judge the outcome of the negotiations".
- On a trade agreement, it is seeking "the broadest and deepest possible partnership" with the EU and is "looking for a deal that goes beyond WTO rules".
- On the European Medicines Agency, it "would like to explore the terms on which the UK could remain part of the European Medicines Agency", and says it cannot pre-judge the negotiations.
- On borders, it "recognise[s] the importance of a border that’s as frictionless as possible" and says post-exit customs arrangements "remain dependent on the outcome of UK-EU negotiations".
- On future immigration and skills, it says the Migration Advisory Committee will report in September, and it will "bring forward proposals for our future immigration system in due course".
Reports
All reportsEvidence
- 1 oral evidence sessionLatest 5 December 2017
Recent activity
- 11th Special Report - The impact of Brexit on the pharmaceutical sector: Government Response to the Committee’s Ninth Report16 July 2018, Report published
- 9th Report - The impact of Brexit on the pharmaceutical sector17 May 2018, Report published
- Oral evidence session5 December 2017, Oral evidence
Reports
Oral evidence sessions
On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.
| Date | Session and witnesses | Source |
|---|---|---|
| 5 Dec 2017 |
Oral evidence session
No witnesses recorded
|
View ↗ |